Sustaining Over Three Years of Zero Central Line-Associated Bloodstream Infections with a Multidisciplinary Team Focus and Phased Interventions

The abstract, which was presented at Association for Vascular Access Annual Scientific Meeting in September 2018, examined the cleaning of needleless connectors and the collection of blood cultures with  3.15% chlorhexidine gluconate (CHG)/70% alcohol (IPA)

Results: Prevantics® Device Swab trial resulted in a statistically significant reduction in CLABSIs.